Delivery Order SPE2DB20D3103-SPE2DB21FQ1M1
- Not listed
- This federal contract award, valued at $1,880.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lamictal 150 mg tablets, a medication used to treat certain types of seizures and bipolar disorder. The contract is a Delivery Order and has a Firm Fixed Price pricing type. It does not have a set-aside designation, indicating open competition....
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a ceiling value of $10,253.17, is for the delivery of Lamictal XR 25 mg tablets, a prescription medication used to treat epilepsy and bipolar disorder. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999, which serves as a primary...
- This federal contract award, valued at $1,413.41, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The award is for the delivery of Lamictal XR 200 mg tablets, a prescription medication used to treat certain types of seizures. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025....
- This federal contract award, valued at $9,006.46, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LAMICTAL XR 200 MG TABLET 30S, a pharmaceutical product, with an ultimate completion date of April 2, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
- This federal contract award, valued at $10,789.09, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Lamictal XR 50 mg tablets, a pharmaceutical product used for the treatment of epilepsy and certain mental health conditions. The contract has a completion date of February 9, 2024 and is a firm-fixed-price delivery order. The contract was awarded through full and open competition and does not have a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,445.64 firm fixed-price contract is for the supply of Lamictal XR 300 mg tablets, a prescription medication used to treat epilepsy and bipolar disorder. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical...
- This is a $5,928.75 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 300 mg Lamictal XR tablets. The contract has a period of performance through July 13, 2022. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $23,470.18 firm fixed-price delivery order is for the supply of Lamictal XR 200 mg tablets, a medication used to treat epilepsy and certain types of mental health conditions. The award is not designated as a set-aside contract. It is associated with a larger Indefinite Delivery Contract (IDC) that...
- This federal contract award, valued at $12,109.41, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for LAMICTAL XR 200 MG TABLET 30S, a medical product, with a completion date of February 14, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This federal contract award, valued at $30,158.73, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract covers the delivery of Lamictal XR 200 mg tablets, a medication used in the treatment of mental health conditions. The contract has a firm fixed-price pricing type and an ultimate completion date of October 28, 2024. Amerisourcebergen, a for-profit organization registered in the System for Award Management...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB21FQ1M1Delivery Order
This federal contract award, valued at $1,531.33, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lamictal XR 50 mg tablets, a prescription medication used to treat certain types of seizures and bipolar disorder. The award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract was awarded through full and open competition without any set-aside designations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 9/3/21 |